GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Cannabis Strategic Ventures (OTCPK:NUGS) » Definitions » Debt-to-Revenue

Cannabis Strategic Ventures (Cannabis Strategic Ventures) Debt-to-Revenue : 1.65 (As of Jun. 2020)


View and export this data going back to 2005. Start your Free Trial

What is Cannabis Strategic Ventures Debt-to-Revenue?

Debt-to-Revenue measures a company's ability to pay off its debt.

Cannabis Strategic Ventures's Short-Term Debt & Capital Lease Obligation for the quarter that ended in Jun. 2020 was $15.09 Mil. Cannabis Strategic Ventures's Long-Term Debt & Capital Lease Obligation for the quarter that ended in Jun. 2020 was $7.11 Mil. Cannabis Strategic Ventures's annualized Revenue for the quarter that ended in Jun. 2020 was $13.49 Mil. Cannabis Strategic Ventures's annualized Debt-to-Revenue for the quarter that ended in Jun. 2020 was 1.65.

Cannabis Strategic Ventures Debt-to-Revenue Historical Data

The historical data trend for Cannabis Strategic Ventures's Debt-to-Revenue can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Cannabis Strategic Ventures Debt-to-Revenue Chart

Cannabis Strategic Ventures Annual Data
Trend Dec13 Dec14 Mar16 Mar17 Mar18 Mar19 Mar20
Debt-to-Revenue
Get a 7-Day Free Trial N/A N/A - 0.89 9.06

Cannabis Strategic Ventures Quarterly Data
Sep15 Dec15 Mar16 Jun16 Sep16 Dec16 Mar17 Jun17 Sep17 Dec17 Mar18 Jun18 Sep18 Dec18 Mar19 Jun19 Sep19 Dec19 Mar20 Jun20
Debt-to-Revenue Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 22.81 6.31 3.53 17.47 1.65

Competitive Comparison of Cannabis Strategic Ventures's Debt-to-Revenue

For the Drug Manufacturers - Specialty & Generic subindustry, Cannabis Strategic Ventures's Debt-to-Revenue, along with its competitors' market caps and Debt-to-Revenue data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Cannabis Strategic Ventures's Debt-to-Revenue Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Cannabis Strategic Ventures's Debt-to-Revenue distribution charts can be found below:

* The bar in red indicates where Cannabis Strategic Ventures's Debt-to-Revenue falls into.


Cannabis Strategic Ventures Debt-to-Revenue Calculation

Debt-to-Revenue measures a company's ability to pay off its debt.

Cannabis Strategic Ventures's Debt-to-Revenue for the fiscal year that ended in Mar. 2020 is calculated as

Debt-to-Revenue=Total Debt / Revenue
=(Short-Term Debt & Capital Lease Obligation + Long-Term Debt & Capital Lease Obligation) / Revenue
=(13.83 + 7.624) / 2.367
=9.06

Cannabis Strategic Ventures's annualized Debt-to-Revenue for the quarter that ended in Jun. 2020 is calculated as

Debt-to-Revenue=Total Debt / Revenue
=(Short-Term Debt & Capital Lease Obligation + Long-Term Debt & Capital Lease Obligation) / Revenue
=(15.089 + 7.111) / 13.492
=1.65

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

In the calculation of annual Debt-to-Revenue, the Revenue of the last fiscal year is used. In calculating the annualized quarterly data, the Revenue data used here is four times the quarterly (Jun. 2020) Revenue data.

Cannabis Strategic Ventures Debt-to-Revenue Related Terms

Thank you for viewing the detailed overview of Cannabis Strategic Ventures's Debt-to-Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.

Cannabis Strategic Ventures (Cannabis Strategic Ventures) Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Cannabis Strategic Ventures (OTCPK:NUGS) » Definitions » Debt-to-Revenue
Comparable Companies
RDGC AKRX TLGT TRTC KGKG CPHI ZCOR PRPH GPFT ALIM ZTS TSE:4502 XTER:MRK HKSE:03692 TSE:4523 SZSE:000661 TSE:4507 SZSE:000538 NSE:SUNPHARMA SZSE:300601
Traded in Other Exchanges
N/A
Address
9350 Wilshire Boulevard, Suite 203, Beverly Hills, CA, USA, 90212
Website
https://www.cannabisstrategic.com
Cannabis Strategic Ventures focuses on the medical and legal recreational cannabis sector. It provides temporary, permanent, and long-term staffing solutions, employment and human resources consulting to the legal Cannabis sector.
Executives
Gordon Samson director, officer: Chief Financial Officer 9595 WILSHIRE BLVD., SUITE 900 BEVERLY HILLS CA 90212
Dane Brown director, officer: VP, Corporate Development 9595 WILSHIRE BOULEVARD, SUITE 900 BEVERLY HILLS CA 90212
Christopher G Foster director, officer: CFO, Secretary & Treasurer 5151 E. BROADWAY, SUITE 1600, TUCSON AZ 85711
Robert Hoegler director, 10 percent owner, officer: President #604 7040 GRANVILLE AVENUE RICHMOND A1 V6Y 3W5
Floyd Flaman director, 10 percent owner, officer: SECRETARY/TREASURER 5621 52ND STREET DELTA A1 V4K 2C7
Scott Marshall director, 10 percent owner, officer: President 2435 WEST 7TH AVENUE VANCOUVER A1 00000